INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2013
Total net assets |
£154.8m |
NAV per share |
280.6p |
Share price |
248.0p |
Total value of unquoted investments |
£25.2m |
Total number of portfolio companies |
70 |
Cash |
3% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
13.26% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Gilead Celgene |
7.0 6.2 6.0 |
Onyx |
4.8 |
Aptiv |
3.7 |
Alexion |
3.6 |
Celldex |
3.4 |
Insulet |
2.9 |
Cepheid |
2.4 |
Biomarin |
2.3 |
|
----------- |
Total |
42.3 |
Geographical Allocation |
% |
United States & Canada |
88 |
Europe |
9 |
Cash |
3 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
81 |
Unquoted |
16 |
Cash |
3 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 MAY 2013